# ğŸ“Š COVID-19 Clinical Trials EDA using Pandas

# Author: Lakshmi Yuvaraj

# ğŸ§ª Project Overview

The COVID-19 pandemic triggered a massive global research effort, resulting in thousands of clinical trials. This project explores publicly available datasets from ClinicalTrials.gov to analyze the scope, focus, and evolution of these trials using Python, Pandas, and data visualization tools.

# ğŸ¯ Objectives

Explore characteristics of COVID-19 clinical trials

Analyze trial phases, statuses, study designs, participant demographics

Discover trends in conditions, interventions, locations, and sponsors

Understand how research focus evolved over time

# ğŸ”§ Steps Involved

Data Import & Preprocessing

Exploratory Data Analysis (EDA)

Univariate Analysis

Bivariate Analysis

Time Series Analysis

Feature Engineering

Data Visualization

# ğŸ“ Data Source

File: COVID clinical trials.csv

Source: ClinicalTrials.gov

Content: Details of global clinical trials focused on COVID-19 including status, sponsor, phase, enrollment, country, and interventions.

# ğŸ“Š Key Analyses & Visualizations

Distribution of Clinical Trial Statuses

Phase-wise Trial Distribution

Enrollment by Age Groups

Heatmaps & Word Clouds

Top 10 Conditions, Interventions, Sponsors, Countries

Time-based trends in trial registrations

# ğŸ’¡ Insights

COVID-19 was the dominant condition in clinical research.

Most trials targeted adults and elderly populations.

Phases 2 and 3 were most commonâ€”focusing on treatment efficacy and safety.

Respiratory conditions like pneumonia and ARDS were frequent study targets.

U.S., China, and European countries led in trial counts.

A decrease in trial initiation was seen post-vaccine rollout.

Diverse and inconsistent outcome measures challenge unified interpretation.

# ğŸ§  Technologies Used

Python (Pandas, Matplotlib, Seaborn, WordCloud)

Jupyter Notebook

PowerPoint for reporting

